Telomerase activity is detected in pancreatic cancer but not in benign tumors

Cancer Research

Volumn 57, Issue 2, 1997, Pages 326-331

  Hiyama, Eiso ^a   Kodama, Takashi ^a   Shinbara, Kanae ^a   Iwao, Toshiyasu ^a   Itoh, Masaki ^a   Hiyama, Keiko ^a   Shay, Jerry W ^b   Matsuura, Yuichiro ^a   Yokoyama, Takashi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CANCER DIAGNOSIS; CELL IMMORTALIZATION; CLINICAL ARTICLE; DNA SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PANCREAS CANCER; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATITIS; PRIORITY JOURNAL; TUMOR CELL;

CHRONIC DISEASE; HUMANS; NEOPLASM PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; TELOMERASE;

EID: 0031015729     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lillemoe, K. D. Current management of pancreatic carcinoma. Ann. Surg., 211: 133-148, 1995.
2. Warshaw, A. L. Pancreatic carcinoma. N. Engl. J. Med., 326: 455-465, 1992.
3. Niederau, C., and Grendell, J. H. Diagnosis of pancreatic carcinoma. Pancreas, 7: 66-86, 1992.
4. Bos, J. L. Ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
5. Casey, G., Yamanaka, Y., Friess, H., Kobrin, M. S., Lopes, M. E., Buchler, M., Beger, H. G., and Korc, M. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett., 69: 151-160, 1993.
6. Barton, C. M., Staddon, S. L., Hughes, C. M., Hall, P. A., O'Sullivan, C., Kloppel, G., Theis, B., Russell, R. C. G., Neoptolemos, J., Williamson, R. C. N., Lane, D. P., and Lemoine, N. R. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br. J. Cancer, 64: 1076-1082, 1991.
7. Endo, Y., Morii, J., Tamura, N., and Okuda, S. Cytodiagnosis of pancreatic malignant tumors by aspiration under direct vision, using a duodenal fiberscope. Gastroenterology, 67: 944-951, 1974.
8. Ryan, M. Cytologic brushing of duodenal lesions during ERCP. Gastrointest. Endosc., 37: 139-142, 1991.
9. Nakaizumi, A., Tatsuta, M., Uehara, H., Yamamoto, R., Takenaka, A., Kishigami, Y., Takemura, K., Kitamura, T., and Okuda, S. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. Cancer (Phila.), 70: 2610-2614, 1992.
10. Tada, M., Omata, M., and Ohto, M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology, 100: 233-238, 1991.
11. Kondo, H., Sugano, K., Fukuyama, N., Kyogoku, A., Nose, H., Shimada, K., Ohkura, H., Ohtsu, A., Yoshida, S., and Shimosato, Y. Detection of point mutation in K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer (Phila.), 73: 1589-1594, 1994.
12. Digiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M. van den Berg, F. M., Allison, D. C., Cameron, J. L., and Offerhaus, J. A. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am. J. Clin. Pathol., 101: 684-688, 1994.
13. Ishimizu, S., Itoh, M., Hanada, K., Tsuchida, A., Iwao, T., and Kajiyama, G. Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer (Phila.), 77: 2233-2239, 1996.
14. Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., and Sninsky, J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53: 2472-2474, 1993.
15. Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., and Omata, M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 110: 227-231, 1996.
16. Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X., and Perucho, M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J. Cancer, 58: 185-191, 1994.
17. Greider, C. W., and Blackburn, E. H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell, 43: 405-413, 1985.
18. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-529, 1989.
19. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. The RNA component of human telomerase. Science (Washington DC), 269: 1236-1241, 1995.
20. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
21. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
22. Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., and Shay, J. W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci., 17: 1-15, 1995.
23. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med., 1: 249-255, 1995.
24. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 895-902, 1995.
25. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55: 2533-2536, 1995.
26. Tahara, H., Nakanishi, T., Kitamoto, M., Nakashio, R., Shay, J. W., Tahara, E., Kajiyama, G., and Ide, T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res., 55: 2734-2736, 1995.
27. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., and Matsuura, Y. Telomerase activity in gastric cancer. Cancer Res., 55: 3258-3262, 1995.
28. Hiyama, E., Gollahan, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W. Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 116-122, 1996.
29. Hiyama, E., Gollahan, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., and Shay, J. W. Telomerase activity in human breast tumors. J. Natl. Cancer Inst., 88: 839-840, 1996.
30. Wright, W. E., Shay, J. W., and Piatyszek, M. A. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acid Res., 23: 3794-3795, 1995.
31. Taylor, R. S., Ramirez, R. D., Ogoshi, M., Chaffins, M., Piatyszek, M. A., and Shay, J. W. Detection of telomerase activity in malignant and nonmalignant skin condition. J. Invest. Dermatol., 106: 759-765, 1996.
32. Zhang, W., Piatyszek, M. A., Kobayashi, T., Estey, E., Andreff, M., Deisseroth, A. B., Wright, W. E., and Shay, J. W. Telomerase activity in acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agent. Clin. Cancer Res., 2: 799-803, 1996.
33. Hiyama, E., Hiyama, K., Yokoyama, T., Ichikawa, T., and Matsuura, Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn. J. Cancer Res., 83: 159-164, 1992.
34. Hiyama, K., Ishioka, S., Shirotani, Y., Inai, K., Hiyama, E., Murakami, I., Isobe, T., Inamizu, T., and Yamakido, M. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene, 10: 937-944, 1995.
35. Hiyama, E., Yokoyama, T., Hiyama, K., Yamakido, M., Santo, T., Kodama, T., Ichikawa, T., and Matsuura, Y. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int. J. Oncol., 6: 13-16, 1995.
36. Shay, J. W. Aging and cancer: are telomeres and telomerase the connection? Mol. Med. Today, 1: 378-384, 1995.
37. Hiyama, K., Hirai, Y., Kyouizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., and Yamakido, M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol., 155: 3711-3715, 1995.
38. Hiyama, E., Hiyama, K., Tatsumoto, N., Kodama, T., Shay, J. W., and Yokoyama, T. Telomerase activity in human intestine. Int. J. Oncol., 9: 453-458, 1996.
39. de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., and Varmus, H. E. Structure and variability of human chromosome ends. Mol. Cell. Biol., 10: 518-527, 1990.
40. Sharma, M. P., Gregg, J. A., Loewenstein, M. S., McCabe, R. P., and Zamcheck, N. Carcino-embryonic antigen activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. Cancer (Phila.), 35: 2457-2461, 1976.
41. Wakabayashi, T., Sawabu, N., Takemori, Y., Satomura, Y., Kidani, H., Ohta, H., Watanabe, H., Yamakawa, O., Takahashi, H., Watanabe, K., and Konishi, F. Diagnostic significance of cancer-associated carbohydrate antigen (CA19-9) concentrations in pancreatic juice: analysis in pure pancreatic juice collected by endoscopic aspiration and immunohistochemical study in chronic pancreatitis. Pancreas, 8: 151-159, 1993.
42. Nishida, K., Yoshikawa, T., Fukumoto, K., and Kondo, M. Elevated pancreatic onco-fetal antigen levels measured by enzyme immunoassay in pure pancreatic juice of patients with pancreatic cancer. Oncology, 43: 311-315, 1986.